Abatti L, Lado-Fernandez P, Huynh L, Collado M, Hoffman M, Mitchell J
Nucleic Acids Res. 2023; 51(19):10109-10131.
PMID: 37738673
PMC: 10602899.
DOI: 10.1093/nar/gkad734.
Rodriguez Calleja L, Lavaud M, Tesfaye R, Brounais-Le-Royer B, Baudhuin M, Georges S
Cancers (Basel). 2022; 14(23).
PMID: 36497429
PMC: 9741383.
DOI: 10.3390/cancers14235948.
Cao B, Wang P, Gu L, Liu J
Oncol Lett. 2021; 21(4):249.
PMID: 33664813
PMC: 7882885.
DOI: 10.3892/ol.2021.12510.
Peng S, Li X, Liu Q, Zhang Y, Zou L, Gong X
Nan Fang Yi Ke Da Xue Xue Bao. 2019; 39(6):641-649.
PMID: 31270041
PMC: 6743921.
DOI: 10.12122/j.issn.1673-4254.2019.06.03.
Gaspar T, Sa A, Lopes J, Sobrinho-Simoes M, Soares P, Vinagre J
Genes (Basel). 2018; 9(5).
PMID: 29751586
PMC: 5977181.
DOI: 10.3390/genes9050241.
Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.
Tai S, Chien H, Young C, Tsao C, De Pablo A, Fan K
World J Surg Oncol. 2017; 15(1):47.
PMID: 28209200
PMC: 5314474.
DOI: 10.1186/s12957-017-1116-5.
Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma.
Vallejo-Diaz J, Olazabal-Moran M, Cariaga-Martinez A, Pajares M, Flores J, Pio R
Oncotarget. 2016; 7(51):85063-85078.
PMID: 27835880
PMC: 5356720.
DOI: 10.18632/oncotarget.13195.
ZNF703 Overexpression may act as an oncogene in non-small cell lung cancer.
Baykara O, Dalay N, Kaynak K, Buyru N
Cancer Med. 2016; 5(10):2873-2878.
PMID: 27650486
PMC: 5083741.
DOI: 10.1002/cam4.847.
The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
Fields A, Justilien V, Murray N
Adv Biol Regul. 2016; 60:47-63.
PMID: 26754874
PMC: 4729592.
DOI: 10.1016/j.jbior.2015.10.009.
Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.
Zang X, Chen M, Zhou Y, Xiao G, Xie Y, Wang X
Cancer Inform. 2015; 14(Suppl 2):183-91.
PMID: 26052221
PMC: 4444140.
DOI: 10.4137/CIN.S17287.
Amplification of chromosome 8 genes in lung cancer.
Baykara O, Bakir B, Buyru N, Kaynak K, Dalay N
J Cancer. 2015; 6(3):270-5.
PMID: 25663945
PMC: 4317763.
DOI: 10.7150/jca.10638.
Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosis.
Avila-Moreno F, Armas-Lopez L, Alvarez-Moran A, Lopez-Bujanda Z, Ortiz-Quintero B, Hidalgo-Miranda A
PLoS One. 2014; 9(12):e114104.
PMID: 25460568
PMC: 4252097.
DOI: 10.1371/journal.pone.0114104.
NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma.
Kim K, Myers C, Jung D, Lu B
Genes Cancer. 2014; 5(7-8):293-302.
PMID: 25221647
PMC: 4162139.
DOI: 10.18632/genesandcancer.27.
Targeting the PI3-kinase/Akt/mTOR signaling pathway.
Hassan B, Akcakanat A, Holder A, Meric-Bernstam F
Surg Oncol Clin N Am. 2013; 22(4):641-64.
PMID: 24012393
PMC: 3811932.
DOI: 10.1016/j.soc.2013.06.008.
True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs.
Brunelli M, Bria E, Nottegar A, Cingarlini S, Simionato F, Calio A
PLoS One. 2012; 7(12):e49689.
PMID: 23236352
PMC: 3516520.
DOI: 10.1371/journal.pone.0049689.
Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.
Cai Y, Zhang H, Zhang Z, Mu J, Li Z
Oncol Lett. 2012; 2(2):257-264.
PMID: 22866074
PMC: 3410566.
DOI: 10.3892/ol.2010.229.
Role of p63 in Development, Tumorigenesis and Cancer Progression.
Bergholz J, Xiao Z
Cancer Microenviron. 2012; 5(3):311-22.
PMID: 22847008
PMC: 3460051.
DOI: 10.1007/s12307-012-0116-9.
Genetic changes in squamous cell lung cancer: a review.
Heist R, Sequist L, Engelman J
J Thorac Oncol. 2012; 7(5):924-33.
PMID: 22722794
PMC: 3404741.
DOI: 10.1097/JTO.0b013e31824cc334.
Pulmonary adenocarcinoma: a renewed entity in 2011.
Kadara H, Kabbout M, Wistuba I
Respirology. 2011; 17(1):50-65.
PMID: 22040022
PMC: 3911779.
DOI: 10.1111/j.1440-1843.2011.02095.x.
Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).
Ji M, Guan H, Gao C, Shi B, Hou P
BMC Cancer. 2011; 11:147.
PMID: 21507233
PMC: 3098185.
DOI: 10.1186/1471-2407-11-147.